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Lactococcins: Mode of Action, Immunity and Secretion 
K. Venema, G. Venema,* & J. Kok 
Department of Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, 
University of Groningen, Kerklaan 30, 9751 NN Haren, The Netherlands 
ABSTRACT 
Lactococcus lactis subsp. cremoris 9B4 produces three small (around SkDa), heat- 
stable, non-lanthionine containing, membrane active bacteriocins. Amino acid 
uptake experiments andproton motiveforce measurements have indicated that these 
peptides most probably form pores in the cytoplasmic membrane of sensitive cells. 
For bacteriocin activity a membrane protein (receptor) is necessary. The bacter- 
iocin producing strain protects itself against the deleterious action of the bacteriocin 
by producing an immunity protein expressed from the same operon. The immunity 
protein works by blocking the receptor, thereby preventing the bacteriocin to form 
pores. 
The producer cell most probably secretes these peptides by a set-independent 
transport machinery, homologous to the E. cob haemolysin secretion system. Two 
membrane-located proteins (LcnC and LcnD) are necessary for extracellular, 
active bacteriocin. By PhoAILacZ fusion studies the topology of LcnD has been 
determined. The protein contains one transmembrane a-helix near its N-terminus. 
The N-terminus is located inside, the C-terminus is on the outside of the cell. LcnC 
most probab1.v contains six transmembrane helices. The present model suggests that 
both membrane proteins are necessary for export of the bacteriocins, forming a 
dedicated transport-machinery of the ATP-binding cassette family. 
INTRODUCTION 
The past several years have seen an explosion of research activity on bacteriocins 
produced by lactic acid bacteria (LAB) (De Vuyst, 1993; Hoover & Steenson, 
1993; James et al., 1992; Jung & Sahl, 1991; Klaenhammer, 1988, 1993; Kolter & 
Moreno, 1992; Ray et al., 1992; Nettles & Barefoot, 1993). As this field continues 
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to expand, our knowledge about LAB and their bacteriocins is increasing rapidly, 
owing to detailed studies of the peptides, their mechanism of action, immunity-, 
processing and secretion systems, and the genes involved in these processes. Here 
we focus on lactococcins, peptide bacteriocins produced by L. lactis. For data on 
other (similar) bacteriocins the reader is referred to the excellent reviews that 
appeared recently (Klaenhammer, 1993; Nettles & Barefoot, 1993; Kok et al., 
1993). 
Bacteriocins, as defined by Tagg et al. (1976), are proteinaceous compounds 
that kill closely related bacteria. This definition is true for the majority of 
bacteriocins investigated, but gradually it has become evident that certain 
bacteriocins may also elicit bactericidal activity against bacterial species that are 
not closely related to the bacteriocin producer. Moreover, there are examples of 
bacteriocinogenic complexes of a protein and another heterogeneous moiety that 
is required for activity and may include lipid or carbohydrate (Schved et al., 1993; 
Jimenez-Diaz et al., 1993; Lewus et al., 1992; Upreti & Hinsdill, 1973; Upreti & 
Hinsdill, 1975). 
Several bacteriocins of LAB have been characterized biochemically and 
genetically and of a number the mode of action has been studied. This allowed 
the classification of these bacteriocins into four distinct classes [as proposed by 
Klaenhammer (1993)]: 
(i) lantibiotics; small membrane-active peptides that contain the unusual 
amino acids lanthionine, P-methyl lanthionine, dehydro-alanine and 
dehydro-butyrine; e.g. lactocin S, carnocin U149, lacticin 481 and nisin 
(Hurst, 1981; Piard et al., 1993; Stoffels et al., 1992; Mortvedt et al., 1991; 
Kaletta & Entian, 1989). Nisin is the best studies example and will be 
dealt with by Oscar Kuipers separately in this issue; 
(ii) small (< 5 kDa) heat-stable, non-lanthionine containing membrane active 
peptides characterized by a double glycine processing site in the bacter- 
iocin precursors. This site is not entirely restricted to this class; it is also 
present in some lantibiotics. Most of the bacteriocins characterized to 
date, including the lactococcins, belong to this class which may be divided 
into three subclasses: 
(a) bacteriocins that are active on Listeria; the so-called pediocin-like 
bacteriocins (Nieto-Lozano et al., 1992); e.g. pediocin PA-l, sakacin 
A and P and curvacin A (Nieto Lozano et al., 1992; Holck et al., 
1992; Tichaczek et al., 1992; Marugg et al., 1992); 
(b) complexes that consist of two proteinaceous peptides required for 
activity; e.g. lactacin F, lactococcin G and lactococcin M (Nissen- 
Meyer et al., 1992; Allison et al., 1993; Van Belkum et al., 1991a); 
(c) thiol-activated bacteriocins. The only example so far known is lacto- 
coccin B (Venema et al., 1993); 
(iii) large ( > 30 LDA) heat-labile proteins; e.g. helveticin J, helveticin V-1829, 
lactacins A and B (Joerger & Klaenhammer, 1986; Joerger & Klaenham- 
mer, 1990; Toba et al., 1991; Vaughan et al., 1992); 
(iv) complex bacteriocins, composed of protein plus one or more non-protei- 
naceous moieties (lipid, carbohydrate) required for activity; e.g. leucocin 
S, lactocin 27 and pediocin SJ-1 (Schved et al., 1993; Jimenez-Diaz et al., 
1993; Lewus et al., 1992; Upreti & Hinsdill, 1973, 1975). 
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Fig. 1. Plasmid p9B4-6 and location of the three operons for lactococcins A, B and M 
(adapted from Kok et al., 1993). The linear map represents a reconstruction based on 
nucleotide sequence data and restriction enzyme analyses (Van Belkum et al., 1989, 
1992; Ho10 et al., 1991; Scherwitz-Harmon & McKay, 1987). The baseline represent the 
DNA sequence and is shown with restriction enzyme cutting sites. Where the line is 
broken, no nucleotide sequence data is available. The direction of transcription is indi- 
cated by arrowheads in the open reading frames. The right/left turn arrows indicate 
promoters. Lollipops are presumed terminator structures. Below the baseline the size of 
the ORF’s in codons is indicated. C, D, A, iA, B, iB, M, N, iM: lcnC, IcnD, lcnA, lciA, 
IcnB, lciB, lcnM, 1cnN and IciM, respectively. EV, HIII: EcoRV and HindIII, respec- 
tively. 
GENETICS OF LACTOCOCCIN PRODUCTION 
In the most thouroughly characterized examples studied so far, the genes speci- 
fying lactococcin production, immunity and secretion are plasmid located (Van 
Belkum et al., 1989; Van Belkum et al., 1992; Ho10 et al., 1991; Scherwitz et al., 
1983). As an example p9B4-6 from L. lactis subsp. cremoris 9B4 is shown in 
Fig. 1. From nucleotide sequence and mutational analyses it became clear that 
this particular plasmid (and probaly also pNP2 of L. Zuctis subsp. lactis biovar. 
diacetylactis WM4 and the 55-kb bacteriocin plasmid of L. lactis subsp. cremoris 
LMG2 130) contains three bacteriocin operons, specifying three different 
bacteriocins, lactococcin A, B and M, and their corresponding immunity 
proteins. In addition there is at least one operon present specifying proteins 
required for lactococcin secretion and processing, namely LcnC and LcnD. In 
the following we will deal with what is known of the separate genes and gene 
products. 
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LACTOCOCCIN STRUCTURAL AND IMMUNITY GENES 
Van Belkum et al. (1991a, 1992) determined the nucleotide sequences of three 
different bacteriocin determinants from plasmid p9B4-6, specifying low (lacto- 
coccin M), high (lactococcin A) and intermediate (lactococcin B) bacteriocin 
activity. In detailed mutational analyses the lactococcin structural and immunity 
genes were identified (Fig. 1). Both genes of 69 (IcnM) and 77 (ZcnN) codons of 
the lactococcin M determinant were implicated in the production of the bacter- 
iocin (Van Belkum et al., 1991a). Separate expression of 1cnM and ZcnN and 
mixing of the supernatants of these strains, gave full bacteriocin activity, whereas 
the separate supernatants were inactive (K. Venema, unpublished results). This 
indicated that lactococcin M is a member of the IIb class of bacteriocins, in which 
a complex of two peptides is required for activity. In the case of the high-and 
intermediate-activity determinants, the ORFs of 75 (ZcnA) and 68 (Zcnl3) codons 
were shown to be involved in the production of lactococcin A and B, respectively. 
This extensive genetic analysis convincingly illustrated that the bactericidal action 
of a strain may, in fact, reflect the activity of more than one bacteriocin. 
Conclusive evidence that ZcnA was indeed the structural gene of lactococcin A 
came from Ho10 et al. (1991). These authors cloned and sequenced a DNA frag- 
ment from the 55-kb bacteriocin plasmid from strain LMG2130 that reacted with 
a DNA probe designed from the N-terminal amino acid sequence of purified 
lactococcin A. The nucleotide sequence appeared to be identical to that of the 
high-activity determinant of p9B4-6. By comparing the amino acid sequence 
determined from the purified bacteriocin with that deduced from the structural 
gene, it was evident that lactococcin A was synthesized as a 75-amino-acid- 
precursor with an N-terminal extension of 21 amino acids. Processing of this 
precursor takes place behind a glycine doublet (Fig. 2). The N-terminal extension, 
hereafter called leader peptide, and the processing site do not follow the rules of 
Von Heijne (1983) for genuine signal peptides required for set-dependent protein 
export, which suggests that the extension in pre-lactococcin A is not a signal 
sequence in its classical sense (Ho10 et al., 1991). LcnB, M and N all contain N- 
terminal sequences with homology to the lactococcin A leader peptide (Fig. 2). 
Although the latter three bacteriocins have not been purified, it is tempting to 
assume that they are also processed behind the glycine doublet (or glycineserine 
. 
LcnA MKNQL---------NFNIVSDEELSEANGG KLTFIQSTAAGDLYYNTNT 40 
LcnB MKNQL---------NFNIVSDEELAEVNGG SLQYVMSAGPYTWYKDTRT 40 
LCnM MKNQL---------NFEILSDEELQGINGG IRGTGKGLAAAMVSGAAMG 40 
LcnN MKKDEANTFKEYSSSFAIVTDEELENINGS GSIWGAIAGGAVKGAIAAS 49 
** * **.**** .**. 
LcrlA HKYVYQQTQNAFGWTIVNGWMGGAAGGFGLHH 75 
LcnB GKTICKQTIDTASYTFGVMAEGWGKTFH 68 
LcnM GAIGAFGGPVGAIMGAWGGAVGGAMKYSI 69 
LcnN WTGNPVGIGMSALGGAVLGGVTYARPVH 77 
Fig. 2. Alignment of LcnA, B, M and N. (*), (.): identical and conserved residue, respec- 
tively. The arrowhead indicates the processing site for LcnA and the presumed processing 
site for the other peptides. The sequence that could possibly form a membrane-spanning a- 
helix is underlined in LcnA. 
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sequence in the case of LcnN). The glycine processing site is found in numerous 
class II peptide bacteriocins of LAB, and even in some lantibiotics and colicin V, 
an E. coli bacteriocin (Hastings et al., 1991; Marugg et al., 1992; Fremaux et al., 
1993; Quadri et al., 1994; Tichaczek et al., 1992; Havarstein et al., 1994, Hynes 
et al., 1993). 
Van Belkum et al. (1991a, 1992) made deletion or frameshift mutations in 
either of the three larger genes, expected to be the immunity genes [the genes of 
154, 98 and 91 codons for the lactococcin M, A and B determinants, respectively, 
(Fig. l)] without disturbing the corresponding bacteriocin structural genes. 
Unexpectedly, L. lactis transformants carrying the various constructs proved 
viable, although the colonies were initially small and grew poorly. After serial 
transfers in fresh medium the cells gradually started to grow more rapidly. If 
lactococcin [50% (vol/vol) of a supernatant of a lactococcin producing strain] 
was added to the plates on which the initial transformants were to be selected, no 
transformants were obtained. Also, when the presumed immunity genes were 
cloned separately from the bacteriocin genes under the control of a promoter, 
they provided immunity to the transformed lactococcal strain. These results 
indicated that the presumed immunity genes indeed specify bacteriocin immunity, 
and also that cells can overcome the lethal action of lactococcin at a stage when 
little bacteriocin is produced. Several possibilities leading to tolerance towards 
lactococcin can be envisaged at this point, one of which, in the case of lactococcin 
A, is the loss or mutational alteration of its receptor (see below). The number of 
transformants obtained with a plasmid carrying IcnA and a mutated immunity 
gene is the same as that obtained with a plasmid carrying functional 1cnA and 
1ciA (K. Venema, unpublished results). Apparently, the absence of a functional 
immunity gene does not interfer with the viability of these transformants. It is 
unlikely that each of the viable transformants would carry a mutation in the 
lactococcin receptor. A more likely explanation is that the viability of these 
transformants is due to a non-genetic change in membrane-lipid composition, 
such that the lactococcin cannot form pores in the altered membranes. Because of 
the frequent occurrence of the acquisition of tolerance towards lactococcin, we 
envisage this change in lipid composition to be an reversible adaptation rather 
than a mutation. Here we will restrict the term immunity to lactococcin-insensi- 
tivity caused by the lci product. We propose to denote the reversible acquisition 
of insensitivity to bacteriocins as tolerance, whereas the term resistance should be 
reserved for permanent acquisition of insensitivity to bacteriocins. 
LcnC AND LcnD ARE ESSENTIAL FOR LACTOCOCCIN 
PRODUCTION 
Nucleotide sequence analysis of a 5.2-kb DNA fragment derived from plasmid 
pNP2 of L. lactis subsp. lactis biovar. diacetylactis WM4 revealed that this plasmid 
also specifies lactococcin A (Stoddard et al., 1992). Moreover, it was shown that 
two additional genes were required for bacteriocin activity. These genes, desig- 
nated 1cnC and ZcnD, are located in an operon immediately upstream of the lacto- 
coccin A structural and immunity genes (Fig. 1). Another copy of these genes is 
probably also present upstream of the lactococcin M operon (Kok et al., 1993). 
Tn5 insertions in either 1cnC or lcnD eliminated lactococcin production without 
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negating immunity (Stoddard et al., 1992). A promoter immediately upstream of 
1cnA drives expression of both lactococcin A activity and immunity (Van Belkum 
et al. 1991a). Therefore, loss of lcnC or 1cnD functions were reasoned to impact the 
maturation and/or secretion processes (Stoddard et al., 1992). Comparisons of 
LcnC and LcnD with protein database sequences revealed that these proteins share 
significant similarities to Gram-negative proteins implicated in signal sequence- 
independent secretion pathways. Stoddard et al. (1992) showed that LcnC is a 
member of the HlyB-like family of ATP-binding cassette (ABC) transporters 
(Higgins, 1993; Fath & Kolter, 1993). The similarity is most pronounced in the C- 
terminal stretch of 200 amino acids of LcnC, which contains the ATP-binding 
cassette. Protein structure-predicting computer programs indicate six hydrophobic 
regions in the N-terminus of LcnC which could promote binding at the cytoplasmic 
membrane, a situation similar to HlyB (Gentschev & Goebel, 1992). Hydro- 
phobicity analysis of LcnD indicated that it is largely hydrophilic, with the excep- 
tion of the N-terminal 43 amino acids. This region in LcnD might be a 
transmembrane domain, as was shown for HlyD (see also below) (Schtilein et al., 
1992). LcnD does not show similarity with HlyD, however. These results strongly 
suggested that LcnC and LcnD are required for secretion of the lactococcins via a 
system dedicated to bacteriocin export (Stoddard et al., 1992; Kok et al., 1993). 
Similar dedicated secretion systems have now been proposed for other LAB 
bacteriocins (Marugg et al., 1992; Kuipers et al., 1993). 
It appears that L. lack strains IL1403 carries genes for LcnC and LcnD on its 
chromosome, explaining why plasmids carrying only the bacteriocin structural 
and immunity genes still produced active bacteriocin (Van Belkum et al., 1991a, 
1992; Ho10 et al., 1991). Using a DNA probe encompassing 1cnC and lcnD, in 
Southern hybridizations, a signal with the chromosome of IL1403 was obtained 
(Kok et al., 1993). When probed with the various bacteriocin structural and 
immunity genes, no chromosomal signal was observed (K. Venema, unpublished 
data). Also, PCR products encompassing almost the entire operon were obtained 
using primers designed from the plasmid encoded 1cnC an ZcnD genes (K. 
Venema, unpublised results), indicating that the chromosomally located IcnC and 
fcnD of IL1403 are highly homologous to their plasmid encoded counterparts. 
Part of the chromosomally encoded IcnC was cloned and sequenced. Several 
nucleotide substitutions were found compared to the plasmid encoded ZcnC 
(K. Venema, unpublished data), but none of these led to amino acid changes in 
the translation product. The reduced production of lactococcin in IL1403 carry- 
ing a plasmid with only the bacteriocin operon, as compared to the wild type 
strain carrying all of the essential genes on a plasmid, can be explained by 
assuming that the lower copy number of the chromosomally located genes (most 
probably one) results in a lower secretion efficiency. This conclusion was corro- 
borated by introducing lcnC and IcnD, originating from p9B4, on a plasmid in 
IL1403. This led to a drastically increased production of lactococcin A. 
TOPOLOGY OF LcnD IN THE LACTOCOCCAL CYTOPLASMIC 
MEMBRANE 
The results presented so far indicate that LcnC and LcnD might form a dedicated 
secretion machinery for lactococcins. However, no evidence has been presented to 
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justify such a conclusion. To characterize the putative secretion machinery, 
Franke et al. (1995) used fusions with the E. coli reporter proteins LacZ and 
PhoA to determine the topology of LcnC and LcnD in the cytoplasmic 
membrane. Since the studies with LcnC are still in progress, only the data for 
LcnD will be discussed here. 
Fusions of LacZ, a cytoplasmic protein, to sequences that are normally located 
in the cytoplasm result in an active fi-galactosidase. Fusions between LacZ and 
parts of a protein that are normally extracellular will result in highly reduced 
/?-galatosidase activities. For PhoA, a periplasmic enzyme, the reverse is true 
(Manoil, 1990; Muller ef al., 1993; Boyd et al., 1993). 
Hydrophobicity analysis of LcnD indicates that the stretch of amino acids 
from residue 22 to 38 might form a transmembrane a-helix. The rest of the 
protein is rather hydrophilic. Taking this computer prediction as a guide, Franke 
et al. (1995) constructed four LacZ and four PhoA fusions in front of, in, and 
behind the predicted transmembrane helix and at the complete C-terminal end of 
LcnD. The analysis showed that, indeed, the N-terminus of LcnD was in the 
cytoplasm, the stretch of amino acids between residue 22 to 38 crossed the 
membrane, and the remainder of the protein was located at the outside of the cell. 
PROCESSING OF BACTERIOCINS; INVOLVEMENT OF THE 
ABC-TRANSPORTERS IN PROCESSING 
As discussed above, class II bacteriocins are synthesized as prebacteriocins, 
containing a leader peptide that is cleaved behind a glycine doublet before or 
during transport. Until recently, it was unclear whether the presumed leader 
peptidase activity was also encoded by the bacteriocin operon, or whether it was a 
more general peptidase present elsewhere on the chromosome. The first indica- 
tion that a protein encoded by the bacteriocin operon was involved in this process 
came from studies by Venema et al. (1995, submitted) on the pediocin operon. 
As for lactococcins, production of active pediocin requires, in addition to the 
structural gene, pedal, two additional genes (pedC and pedD) that show homology 
to the proteins involved in set-independent secretion of polypeptides (Marugg et 
al., 1992). PedC has only structural homology to LcnD, whereas PedD has 
considerable amino acid sequence homology to LcnC (49% identity with an over- 
all homology of 67%). The homology of the latter two proteins is not restricted to 
the ABC-box, but extends over the entire polypeptide. This is also the case with 
several other ABC-transporters involved in secretion of bacteriocins that contain 
the double glycine motif in the leader peptide. Notably, a region in the N-terminal 
190 amino acids is conserved in these proteins (Venema et al., 1995). 
E. coli cells containing the complete ped operon (pedABCD) produce active, 
secreted pediocin (Fig. 3A). Apparently, all the information for both secretion 
and processing is present in this operon. Mutations in the structural gene @edA), 
pedC or pedD abolish production of extracellular pediocin activity by E. coli. The 
primary translation product of pedA contains 62 amino acids encompassing the 
18-amino-acid-leader peptide and the 44 amino acids that constitute mature 
pediocin (Marugg et al., 1992). pedA was expressed in E. coli behind the strong 
T7 RNA polymerase promoter. When lysates of this strain were run on an SDS- 
PAA gel and overlayered with pediocin sensitive cells, a faint halo of activity was 
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Fig. 3. The effect of pedC and pedD on pediocin secretion and processing. Ext. ped, int. 
preped, int. ped: extracellular pediocin, intracellular prepediocin and intracellular pediocin 
activity, respectively. (+), (-): activity present and absent, respectively. The presence of the 
various genes (pedA, pedC, pedD) in the E. coli clones (A, B, C, D) is indicated by the 
arrows. For details, see text. 
observed, corresponding to a peptide with a lower electrophoretic mobility than 
that of mature pediocin produced by E. coli containing the complete ped operon. 
Apparently, the primary translation product of pedA is biologically active albeit 
at a very reduced level. No extracellular activity was found in the strain carrying 
pedA alone (Fig. 3B). To determine which of the genes in the operon was 
responsible for pediocin secretion and/or processing, pedC and pedD were 
expressed separately or together in the strain producing prepediocin from the T7 
promoter. When both pedC and pedD were present, active extracellular pediocin 
was produced. However, when only pedC (Fig. 3C) or pedD (Fig. 3D) were 
present, no extracellular activity was found. Lysates of the strain carrying pedA 
and pedC contained prepediocin activity only. However, lysates of the strain 
carrying pedA and pedD showed, in addition to prepediocin activity, an activity 
on the gel that was indistinguishable from that of mature pediocin (Fig. 3D). 
These results conclusively show that both PedC and PedD are involved in secre- 
tion of pediocin. In addition, we demonstrate that PedD is capable of processing 
the pediocin precursor. Since mature pediocin was found intracellularly in the 
strain containing only pedA and pedD, we postulate that the conserved 190- 
amino-acid-domain in the N-terminus of the protein, which is shown to be intra- 
cellular by topology studies (E. Emond, pers. commun.), is involved in processing 
of the leader peptide. The results also show that bacteriocin processing can be 
uncoupled from secretion. 
We predict that, similar to PedD, LcnC will be the processing enzyme for the 
lactococcins. Since cloning of IcnC in E. coli is lethal we have not yet been able to 
verify this prediction. 
MODE OF ACTION OF LACTOCOCCIN A AND B 
Lactococcins A and B specifically inhibit the growth of lactococci. Both are small 
cationic, hydrophobic peptides that structurally resemble several peptide anti- 
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biotics permeabilizing membranes (Gao et al., 1991; Galvez et al., 1991; Kordel & 
Sahl, 1986; Kordel et al., 1988; Schaller et al., 1989). A possible target for their 
action could thus be the cytoplasmic membrane of sensitive cells. Van Belkum 
et al. (1991b) investigated this possibility in detail for lactococcin A. The mode of 
action of purified lactococcin A was studied on whole cells and membrane vesi- 
cles of sensitive and immune lactococcal strains, and on liposomes obtained from 
lactococcal phospholipids. Venema et al. (1993) performed similar studies with 
partially purified lactococcin B on whole cells. At lactococcin concentrations that 
did not affect immune cells, both bacteriocins rapidly dissipated the membrane 
potential (and in the case of lactococcin B also the pH-gradient across the 
membrane) of glucose-energized sensitive cells. A non-metabolizable alanine 
analogue (AIB, 2-cl-amino isobutyric acid) that is taken up in symport with a 
proton [and of which the uptake is thus driven by the proton motive force (pmf) 
(Konings et al., 19891 was rapidly lost from sensitive whole cells treated with 
lactococcin (Van Belkum et al. 1991b; Venema et al., 1993). To show that efflux 
was a direct consequence of permeability changes in the cytoplasmic membrane, 
and not caused by the absence of a pmf, uptake of L-glutamate was studied. 
Glutamate uptake by L. lactis is driven by a phosphate bond-linked unidirec- 
tional process (Poolman et al., 1987) and dissipation of the pmf should, therefore, 
not lead to efflux of accumulated glutamate. However, addition of either lacto- 
coccin to sensitive cells that had accumulated glutamate resulted in the immediate 
efflux of the amino acid, even when the pmf in the cells was dissipated prior to the 
addition of the bacteriocin (Van Belkum et al., 1991b; Venema et al. 1993). These 
results indicated that both lactococcins are able to form pores in the membrane in 
a voltage-independent manner. 
Lactococcin A inhibited leucine uptake in cytoplasmic membrane vesicles from 
sensitive lactococcal cells, but not from vesicles derived from Bacillus subtilis, 
Clostridium acetobutyricum or E. coli membranes (Van Belkum et al., 199lb). 
Liposomes derived from lactococcal phospholipids were not affected by lacto- 
coccin A. From these data, and the observation that lactococcin A specifically 
inhibits lactococcal strains, Van Belkum et al. (199 1 b) concluded that lactococcin 
A forms pores in the cytoplasmic membrane of sensitive cells using a Lacto- 
coccus-specific receptor protein (Van Belkum et al., 1991b). 
A 21-amino acid sequence between residues Ala30 and PheSO in lactococcin 
A (Fig. 2) could possibly form a membrane-spanning cc-helix (Kok et al., 1993). 
Lactococcin A could be anchored to the cytoplasmic membrane of sensitive 
cells by this hypothetical transmembrane helical segment. A large number of 
pore-forming toxins are known to create channels through a “barrel stave” 
mechanism (Ojcius & Young, 1991; Sansom et al., 1991). Pore formation 
requires the molecules to aggregate like barrel staves surrounding a central 
water-filled pore. It is assumed that lactococcin A and lactococcin B form pores 
by this mechanism, although in the case of lactococcin B the method of Kyte & 
Doolittle (1982) does not predict a (clearcut) membrane spanning helix. The 
size of the pore would be dictated by the number of molecules involved in pore 
formation. An indication that different pore sizes can exist was derived from 
the observation that low concentrations of lactococcin B allow leakage of 
protons and ions, whereas for leakage of glutamate 150 times more bacteriocin 
was needed (Venema et al., 1993). Apparently, at low concentrations a multi- 
peptide complex of lactococcin B molecules forms a pore which is too narrow 
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Fig. 4. Effect of LcnB on the membrane potential of glucose-energized lactococcal cells 
(adapted from Venema et al., 1993). A: no addition, + : addition of non-DTT-treated 
LcnB, 0: addition of DTT-treated LcnB, 0: addition of HgC&treated LcnB, 0: addition 
of HgClz-treated LcnB, subsequently reduced with DTT. 
for the passage of amino acids, but allows the passage of protons and other 
ions. 
A prerequisite for lactococcin B activity is that its only cysteine residue is in the 
reduced state (Cys24, Venema et al., 1993). Partially purified lactococcin B was 
almost inactive on whole cells (Fig. 4, curve +). Only after addition of small 
amounts of dithiothreitol (DTT) was lactococcin B capable of dissipating the 
membrane potential (Fig. 4, 0). Reduction of Cys24 by DTT was counteracted 
by HgC12 (Fig. 4, q ), while HgClz-oxidized lactococcin B could be reactivated by 
DTT (Fig. 4, curve 0). 
Cys24 of lactococcin B was replaced via site directed mutagenesis by all other 
possible 19 amino acids. Surprisingly, 16 of the 19 mutants were active, and 
even more so than the wild type bacteriocin. The inactive mutants were the 
ones in which the cysteine had been replaced by a positively charged amino 
acid (Cys24His, Cys24Lys and Cys24Arg; K. Venema, unpublished data). 
Apparently, Cys24 is not essential for activity of lactococcin B. When Cys24 is 
present, oxidation leads to inactivation of lactococcin B. In this regard lacto- 
coccin B resembles a group of thiol-activated toxins in which the reduced state 
of a cysteine residue appears to be essential for the generation of functional 
lesions in toxin-treated membranes (Boulnois et al., 1991). Also in these mole- 
cules the cysteine can be replaced without loss of activity. The reason for inac- 
tivation of lactococcin B by oxidation of Cys24 is unclear, but since all mutants 
carrying a positively charged amino acid at position 24 are inactive, for the 
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bacteriocin to be active a negative or no charge at this specific site is apparently 
essential. 
MODE OF ACTION OF THE IMMUNITY PROTEIN LCIA 
Since lactococcin A is active on membrane vesicles derived from sensitive cells, 
but not on those derived from immune cells, Van Belkum et al. (1991b) concluded 
that the immunity protein, LciA, was present in the membrane. To study the 
mode of action of the immunity protein, we raised monoclonal antibodies against 
the protein (Venema et al., 1994). To facilitate the purification of LciA, for which 
no assay was available, LciA was fused to the C-terminus of the maltose binding 
protein (MBP) of E. coli (Fig. 5). The fusion protein was used to raise mono- 
clonal antibodies. With one of the antibodies directed against the LciA moiety of 
the fusion, LciA was localized in the membrane fraction of fractionated cells of L. 
lactis (Venema et al,, 1994). However, similar amounts of the protein were also 
present in the cytosolic and membrane-associated fractions. LciA was not 
detectable in the supernatant or soluble cell wall fraction. Four deletion variants 
of the MBP-LciA fusion were constructed that contained the N-terminal 80, 60, 
40 and 20 amino acids of LciA fused to MBP (Fig. 5): On Western-blots only the 
full length fusion and the fusion protein containing the 80 N-terminal amino 
acids of LciA reacted with the monoclonal antibody, indicating that its epitope in 
LciA is located in the C-terminus between amino acids 60 and 80. By performing 
ELISA (enzyme-linked-immunosorbent assay) using the monoclonal antibody on 







Fig. 5. MBP-LciA fusions and its deletion derivatives (adapted from Venema et al., 1994). 
MBP, LciA: maltose binding protein and lactococcin A immunity protein, respectively. 1, 
98. 80, 60, 40, 20: amino acid residue number in LciA. The fusions are not drawn to scale. 
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located at the outside of the cytoplasmic membrane of an LciA-producing strain 
(Venema et al., 1994). Right-side-out membrane vesicles derived from a strain 
producing both lactococcin A and the immunity protein did not react with the 
antibody. The same was observed when lactococcin A was added externally to 
right-side-out vesicles derived from a strain producing only LciA. Apparently, the 
bacteriocin shielded the epitope in LciA from reacting with the monoclonal anti- 
body. Right-side-out membrane vesicles of immune as well as sensitive cells were 
treated with proteinase K and subsequently used in leucine uptake experiments. 
Although LciA is cleaved by proteinase K (Venema et al., 1994) immune vesicles 
incubated with the proteinase were not affected by the bacteriocin. However, also 
proteinase K-treated sensitive vesicles became insensitive to the bacteriocin. 
These data suggested that, in addition to digesting LciA, proteinase K had also 
digested the bacteriocin receptor, previously inferred by van Belkum et al. 
(1991b) on the basis of the lactococcin A mode of action studies, rendering the 
membrane vesicles insensitive to the action of lactococcin A. 
Thus far, the results indicate that LciA is present in the cytoplasmic membrane 
and prevents the action of lactococcin A. It could do so by binding and, thus, 
neutralizing the bacteriocin, or by interacting with and blocking the bacteriocin 
receptor. To distinguish between these two possibilities, right-side-out vesicles 
isolated from immune and sensitive cells were fused and the ability of the fused 
membranes to accumulate leucine was examined (Venema et al. 1994). In case LciA 
would bind and neutralize lactococcin A, the fused vesicles would still be immune 
(Fig. 6A). If LciA would block the bacteriocin receptor, the fused vesicles would be 
sensitive because the unblocked receptor molecules contributed by the sensitive 
vesicles would still be able to interact with lactococcin A (Fig. 6B). As leucine 
uptake in the fused vesicles was completely blocked in the presence of lactococcin 
A, we concluded that the immunity protein can not protect the fusion vesicles 
against lactococcin A and, therefore, does not titrate away lactococcin A. These 
data conclusively show that LciA directly interacts with the lactococcin A receptor. 
Nissen-Meyer et al. (1993) have purified the LciA protein by using the physi- 
cochemical characteristics of its deduced amino acid sequence. As judged from its 
amino acid composition and from amino acid sequencing, the immunity protein 
is not post-translationally modified. Protein structure computer programs predict 
that the stretch of amino acids from residue 29 to 47 in LciA could form an 
cr-amphiphilic helix with a strong hydrophobic moment of 0.52 (Fig. 7). All the 
results presented above can be united in a model for LciA topology, in which the 
C-terminus, from residue 48 to 98 and containing the epitope, is at the outside of 
the cell. Residues 29 to 47 might span the cytoplasmic membrane as an 
cl-amphiphilic helix by virtue of its interaction with another transmembrane 
protein, possibly the lactococcin A receptor. The N-terminus of LciA resides on 
the cytoplasmic face of the membrane. A model visualizing the immunity 
mechanism is presented in Fig. 8. This mechanism also provides an explanation 
for the observation that only part of the synthesized immunity protein molecules 
is present in the cytoplasmic membrane. Apparently, this portion is enough to 
interact with all receptors. We envisage the cytoplasmic and membrane-asso- 
ciated fractions to constitute a continuously available reservoir from which 
molecules can be drawn when new receptors are synthesized and inserted into the 
membrane, thus resulting in immediate blocking of the receptor (Venema et al., 
1994). 
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A 
receptor 




Fig. 6. Fusion of immune and sensitive vesicles and expected effect on leucine uptake. A: 
model for the direct interaction of the lactococcin A immunity protein with the bacter- 
iocin. B: model for the interaction of the lactococcin A immunity protein with the bacter- 
iocin receptor. An explanation of the symbols used is given in the inset. 
CONCLUSIONS AND PERSPECTIVES 
From this overview, it is clear that, over the past few years, very significant 
progress has been made in the field of lactococcin production and immunity 
against lactococcins by L. luctis. Apart from the cloning and sequencing of the 
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moment 
0.52 
in LciA that could form an 
side, white part of the helix: 
Fig. 7. Helical wheel representation of residues 29 to 47 
amphipathic helix. Shaded part of the helix: hydrophobic 
hydrophilic side. 
h 
Fig. 8. Model for the complex of the lactococcin A immunity protein with the bacteriocin 
receptor (adapted from Venema et al., 1994). In this model, the bacteriocin receptor (R) is 
depicted as a transmembrane protein. The amphipathic helix in LciA (I) is located in the 
cytoplasmic membrane (CM), such that the hydrophilic side (light shaded area) is tightly 
associated with a hydrophilic area in the receptor (dark shaded area). The bacteriocin (L) 
is still capable of binding to the receptor, thereby shielding the epitope in the C-terminus of 
LciA from interacting with the LciA-specific antibody. The presence of LciA prevents the 
bacteriocin from successful insertion into the cytoplasmic membrane to form pores. N, 
N-terminus. 
structural and immunity genes and genes encoding the secretion machinery, we 
now begin to understand the mode of action of lactococcin A and lactococcin B, 
and the way the lactococcin A immunity protein LciA might work. Although the 
gene specifying the receptor necessary for activity of lactococcin A has, as yet, not 
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been identified, the presumed receptor is likely to be the site of action of the 
immunity protein. In analogy to the system for pediocin secretion, it is likely that 
LcnC and LcnD are involved in processing and secretion of the lactococcins. In 
the coming years we expect that the receptor will be identified and that molecular 
details concerning the mode of action combined with structure-function studies of 
the lactococcins will allow the construction of bacteriocins with enhanced or 
altered activities and broader specificities. 
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